How to explain the dilemma.mp4
From Katarzyna Adamczuk
views
comments
From Katarzyna Adamczuk
SoSTART is a randomised controlled trial for adults with atrial fibrillation after a brain haemorrhage.
Watch and listen to a 9-minute interview with the Chief Investigator about how to explain the therapeutic dilemma about oral anticoagulation for atrial fibrillation after intracranial haemorrhage. He covers these topics:
The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336, VAT Registration Number GB 592 9507 00, and is acknowledged by the UK authorities as a “Recognised body” which has been granted degree awarding powers.
Any views expressed within media held on this service are those of the contributors, should not be taken as approved or endorsed by the University, and do not necessarily reflect the views of the University in respect of any particular issue.
Unless explicitly stated otherwise, all material is copyright © The University of Edinburgh 2021 and may only be used in accordance with the terms of the licence.